PINNACLE FPO [PNI] PNI.AX

Latest Deep Dive · Written · AI research note

Verdict

Deep Dive

Rating

BUY

Confidence

62%

Target price

A$19.50

Upside

▲ 26.5%

Horizon

medium

The analyst recommends accumulating on weakness with a base case fair value of $19 to $20 (20 to 22x NTM EPS), implying roughly 26% upside from $15.41, while the $22.35 consensus target is framed as the bull case. The capital-light model, 0.01x net debt/EV and 3.6% yield support the valuation, and a PEG near 1.2x on ~14% EPS growth is not stretched. However, the entire investment case hinges on net flows and performance fee crystallization across Hyperion, Antipodes, Firetrail and Plato, and the stock already trades at a 62% premium to its own two-year average P/E, so conviction is moderate rather than high.

Executive Summary

•FY2026 NPAT rose 31% to $176.7m and EPS climbed 25% to $0.781, but consensus NTM EPS of $0.89 implies growth decelerating to roughly 14% as the performance fee tailwind normalises
•The 161% net margin is not an error: affiliate profit share flows through as equity accounted income, so the $109.7m reported revenue line materially understates the true economics of the platform
•At $15.41 the stock trades about 17x NTM EPS, a 62% premium to its own two year average P/E of 10.8x, yet 3.1x P/BV sits 28% below its 4.3x average: the multiple debate is the entire investment case
•A capital light model with net debt/EV of 0.01x and a 3.6% yield is defensive, but the $22.35 consensus target needs net flows and performance fee crystallization across Hyperion, Antipodes, Firetrail and Plato to reaccelerate

Financial Snapshot

•Revenue (TTM): $109.7m (management fee and services line only)
•FY2026 NPAT: $176.7m (+31% YoY)
•FY2026 EPS: $0.781 (+25% YoY)
•Net margin: 161% (equity accounted affiliate earnings exceed reported revenue)
•Gross margin: 44.6%
•Operating margin: 26.7%
•ROE: 17.0% (Yahoo), 18.7% (Bloomberg BEST)
•Debt/Equity: 23.4%
•Net debt/EV: 0.01x
•Quarterly build through FY2026: Q1 revenue $0.05b and net income $0.08b, Q2 $0.05b and $0.09b, Q3 $0.07b and $0.13b, Q4 $0.09b and $0.18b
•Dividend yield: 3.62%

Forward Outlook

•NTM consensus EPS: $0.89 (as of 2026-10-30), implying roughly 14% growth off the FY2026 base
•Consensus EBIT: $150.7m (ASX spreadsheet) to $167.6m (Bloomberg)
•Consensus net income: $148.0m
•Consensus revenue: $92.5m
•EBIT growth: 11.2%
•EBITDA growth: 47.8% (likely flattered by a low prior year base)
•FCF growth: 2.6%
•Consensus DPS: $0.04, which appears mis-scaled or quarterly given the 3.62% yield implies about $0.56 annually
•Consensus target price: $22.35
•Net FUM flows by affiliate: Not disclosed in the supplied dataset

Valuation Analysis

•Current price: $15.41 (52 week range $12.16 to $20.24, down 29% over 12 months)
•NTM P/E: about 17.3x on $0.89 EPS (the 24.6x headline uses a stale $0.63 EPS)
•NTM EV/EBIT: about 23x on $167.6m consensus EBIT
•TTM EV/EBIT: 25.9x
•NTM P/S: not cleanly meaningful on the $92.5m management fee line because of equity accounting
•BF P/E 17.4x vs two year average 10.8x (+62% vs average, +0.7 SD, n=25)
•BF EV/Rev 18.1x vs two year average 14.6x (+24% vs average, +0.3 SD, n=30)
•LF P/BV 3.1x vs two year average 4.3x (-28% vs average, -0.5 SD, n=29)
•Implied price at average P/E: $9.54
•Implied price at average EV/Rev: $12.66
•Implied price at average P/BV: $21.34
•Peer comparisons:
•MFG: 15.6x TTM P/E, $2.3b market cap, global equities pure play, flow challenged
•PPT: 33.9x TTM P/E, $2.0b market cap, diversified but carrying restructuring drag
•GQG: 4.2x TTM P/E, $2.9b market cap, single strategy concentration, deep value
•PNI: about 17x NTM P/E, $3.5b market cap, multi affiliate platform, premium to MFG defensible on diversification

Key Risks & Catalysts

Risks

•Performance fee dependency: crystallization timing makes revenue lumpy and creates a hard comparison in any year without strong absolute returns
•Multiple compression: 17.4x BF P/E is 62% above its own two year average, leaving little cushion if flows disappoint
•Key manager concentration: Hyperion, Antipodes and Firetrail drive a large share of FUM and fee revenue
•Net flow risk: sustained outflows at any major affiliate hit both base fees and performance fee potential
•Seed capital and affiliate stake marks can reverse and are difficult to underwrite
•Cost inflation: staff and affiliate profit share keep operating leverage tightly geared to revenue direction

Catalysts

•FY2027 half year result: performance fee crystallization and net flow disclosure
•New affiliate partnerships and seed capital deployment
•AVI acquisition integration into PAM
•Quotation of over 2 million new shares (October 2026), aiding liquidity and index weight
•Reacceleration in NTM EPS revisions above $0.89
•Further affiliate stake monetisation or share issuance

Investment Thesis

Pinnacle is a capital light, multi affiliate asset manager whose true economics are better than the reported revenue line suggests, because affiliate profit share lands as equity accounted income. FY2026 delivered NPAT of $176.7m (+31%) and EPS of $0.781 (+25%), yet the stock has de-rated 29% over the past year as the market questions whether performance fees and flows can persist. That tension is the whole story.

At $15.41, PNI trades about 17x NTM EPS of $0.89, a premium to MFG at 15.6x and a steep discount to PPT at 33.9x. Against its own history the P/E looks expensive (+62% vs the two year average) while the P/BV looks cheap (-28%), a classic signal that the market is pricing peak earnings quality. A forward P/E of 17x on roughly 14% EPS growth is a PEG near 1.2x, not stretched for a business with 0.01x net debt/EV and a 3.6% yield.

Recommendation: accumulate on weakness. Base case fair value of $19 to $20 (20 to 22x NTM EPS), with the $22.35 consensus target as the bull case. The swing factor is net flows and performance fee crystallization across Hyperion, Antipodes, Firetrail and Plato; a clean flow print would validate the re-rating, while a soft one exposes the premium multiple.

Written by AI from financials, consensus, filings and recent news. General information only, not personal financial advice. Consider your own circumstances before acting.

The Equity Analyst

Run your own analysis free

The Equity Analyst writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

Download on the App Store

See the latest research on other stocks